bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

7230 Articles (5723 medRxiv, 1507 bioRxiv)

Most recent first Previous |  Page 3: Articles 21-30  | Next

Effects of COVID-19 lockdown on heart rate variability
Bourdillon, N., Yazdani, S., Schmitt, L., Millet, G. P.
10.1101/2020.07.30.20165118 — Posted: 2020-08-01
The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review.
Mc Evoy, D., McAloon, C. G., Collins, A. B., Hunt, K., Butler, F., Byrne, A. W., Casey, M., Barber, A., Griffin, J. M., Lane, E. A., Wall, P., More, S. J.
10.1101/2020.07.30.20165084 — Posted: 2020-08-01
A prospective study to identify rates of SARS-CoV-2 virus in the peritoneum and lower genital tract of patients having surgery
Jones, D., Faluyi, D., Hamilton, S., Stylianides, N., Ma, K., Duff, S., Machin, N., Edmondson, R.
10.1101/2020.07.30.20165043 — Posted: 2020-08-01
Mathematical modeling of the transmission of SARS-CoV-2 '' Evaluating the impact of isolation in Sao Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of covid-19
Yang, H. M., Lombardi, L. P., Morato Castro, F. F., Yang, A. C.
10.1101/2020.07.30.20165191 — Posted: 2020-08-01
Five approaches to the suppression of SARS-CoV-2 without intensive social distancing
Drake, J., Rohani, P., Dahlin, K., Handel, A.
10.1101/2020.07.30.20165159 — Posted: 2020-08-01
Visualizing and Assessing US County-Level COVID19 Vulnerability
Cahill, G., Kutac, C., Rider, N. L.
10.1101/2020.07.30.20164608 — Posted: 2020-08-01
Quantification of the association between predisposing health conditions, demographic, and behavioural factors with hospitalisation, intensive care unit admission, and death from COVID-19: a systematic review and meta-analysis
Fernandez Villalobos, N. V., Ott, J. J., Klett-Tammen, C. J., Bockey, A., Vanella, P., Krause, G., Lange, B.
10.1101/2020.07.30.20165050 — Posted: 2020-08-01
Self-rated smell ability enables highly specific predictors of COVID-19 status: a case control study in Israel
Karni, N., Klein, H., Asseo, K., Benjamini, Y., Israel, S., Nimri, M., Olstein, K., Nir-Paz, R., Hershko, A., Muszkat, M., Niv, M. Y.
10.1101/2020.07.30.20164327 — Posted: 2020-08-01
Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection
Files, J. K., Boppana, S., Perez, M. D., Sarkar, S., Lowman, K. E., Qin, K., Sterrett, S., Carlin, E., Bansal, A., Sabbaj, S., Long, D. M., Kutsch, O., Kobie, J., Goepfert, P. A., Erdmann, N.
10.1101/2020.07.30.20165175 — Posted: 2020-08-01
High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
Macias, J., Pinilla, A., Lao-Dominguez, F. A., Corma, A., Contreras-Macias, E., Gonzalez-Serna, A., Gutierrez-Pizarraya, A., Fernandez-Fuertes, M., Morillo-Verdugo, R., Trigo, M., Real, L. M., Pineda, J. A.
10.1101/2020.07.30.20165027 — Posted: 2020-08-01

RSS  Collection RSS | JSON

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).